NEW YORK ( TheStreet) -- Amyris (Nasdaq: AMRS) hit a new 52-week low Monday as it is currently trading at $12.13, below its previous 52-week low of $12.38 with 12,418 shares traded as of 9:41 a.m. ET. Average volume has been 264,000 shares over the past 30 days.

Amyris has a market cap of $561.2 million and is part of the health care sector and drugs industry. Shares are down 53% year to date as of the close of trading on Friday.

Amyris, Inc., an integrated renewable products company, offers renewable compounds for a variety of markets. The company has a P/E ratio of 1.5, below the S&P 500 P/E ratio of 17.7.
  • Practice your AMRS trading strategies and win cash in our stock game.

TheStreet Ratings rates Amyris as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, poor profit margins and generally disappointing historical performance in the stock itself. You can view the full Amyris Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.